Legacy Education Crossed $80 Million — So Why Is the Stock Down 21%?

Record revenue, expanding margins, a debt-free balance sheet — and a growth story whose two engines, organic starts and M&A, are both running behind the pitch.

LGCY · Earnings Call · 2026-09-24

A Record the Market Refused to Cheer

Legacy Education just posted the best year in its short public life. Fiscal 2026 revenue rose 24.8% to $80.1 million, adjusted EBITDA climbed 24.1% to $13.6 million, and the fourth quarter showed the operating leverage management has been promising for years: revenue up 12% while total costs and expenses rose only 9.6%. “Adjusted EBITDA margin improved 220 basis points to 15.5% from 13.3%.” — Brandon Pope, Chief Financial Officer or Finance Executive · 2026-09-24 The operating margin held near 15% for the year even as the company funded faculty, labs and infrastructure ahead of the revenue they will generate. And yet the tape wants nothing to do with it. LGCY is down 20.8% over the last 90 days, sitting 22.8% below its July high, inside a longer drawdown that runs roughly a third off the March peak above $14. A small-cap issuing a record print into a falling stock is a setup worth interrogating — and the call supplies the reason. The headline framing is scale and durability. Note the phrase LeeAnn Rohmann reaches for first: “We crossed $80 million in annual revenue, and revenue from our pre-existing brands grew 16.5%.” — LeeAnn Rohmann, Chief Executive Officer or President · 2026-09-24 That distinction matters, because roughly 62% of the year-over-year increase came from businesses Legacy already owned, not from the Contra Costa acquisition. The company is leaning hard on existing platform growth precisely because the acquisition narrative has gone stale.

The Two Engines Running Behind

Two numbers undercut the celebratory tone. First, new student starts rose just 9% for the year but were negative in the quarter — down 4% year over year, following a 12% decline the quarter before. Rohmann's answer to Mike Grondahl's question is instructive and a little defensive: “our leads are not an issue. It really is coming down to from our programs of the Surg Tech, the Sterile Processing ramping up, and the changes that we've made in our VN program.” — LeeAnn Rohmann, Chief Executive Officer or President · 2026-09-24 In other words, demand exists; execution on program readiness and calendar timing is the drag. That is a more forgivable problem than weak demand — but it is a problem the company has now carried for two straight quarters. The second engine is M&A, and this is where the story gets sharper. Legacy has told investors for multiple quarters that a deal is close. On the February call the goal was explicit: “we should be able to definitely hit that goal of doing this before the end of the fiscal year.” — Operator, Operator · 2026-02-12 That fiscal year ended June 30, 2026. No deal was announced. On the May call, Rohmann said, “we are well into looking at a few.” — LeeAnn Rohmann, Chief Executive Officer · 2026-05-14 And now, on the year-end call, the language has hardened into a permanent holding pattern: “we are actively under review and look forward to the opportunity to announce something once we know that it meets our criteria.” — LeeAnn Rohmann, Chief Executive Officer or President · 2026-09-24

I mean, I've expanded as much as I can in the talking points, but I would just tell you that as you look at Legacy's really model and our experience... we are active in acquisitions and we're engaged in it, and we are actively under review.
LeeAnn Rohmann, Chief Executive Officer or President · 2026-09-24

That keyword — acquisition opportunities under active evaluation — is now Legacy's most-repeated line, and the cadence of it, unchanged across three consecutive calls, is itself the signal. This is a company with a fortress balance sheet and no obvious way to deploy it.

What Management Stopped Saying

The vocabulary has quietly rotated. Earlier in the cycle, "new program" was a top-ranked theme; it has since fallen off sharply in the company's language, replaced by softer constructs — "new capacity," "program portfolio," Contra Costa Medical Career College integration, "operating infrastructure." The reason is visible in the call: programs that management once framed as imminent have slipped on regulatory timing. Rohmann acknowledged the pattern directly in May, when she noted the delay had “shortened our marketing runway” — LeeAnn Rohmann, Chief Executive Officer · 2026-05-14 and that the company simply needed more time to fill classes than it had. That admission — that readiness, not demand, gates growth — is the through-line connecting the negative starts to the softer program rhetoric. The genuinely new item is geography. Legacy signed a 28,000-square-foot lease in Houston, its first campus outside California, with a planned November 2026 opening subject to approvals. Rohmann frames the market: “after a 1 to 2 year period, you're going to see between 400 and 600 students in the Houston location.” — LeeAnn Rohmann, Chief Executive Officer or President · 2026-09-24 She also hinted the whole state of Texas could be a broader target, both for branches and deals. That is a real strategic pivot — but note it is a lease, not a new revenue line, and the 400-600 number is a 2028 aspiration.

The Numbers Behind the Story

What supports the bull case is discipline on the cost side and on credit. Liabilities to assets has drifted down to roughly a third of the balance sheet, and the company ended the year with $22.7 million in cash and no debt facility at all — a genuine differentiator for a roll-up. Free cash flow, however, is thin relative to reported earnings: free cash flow less stock comp has been volatile and small, and the soft spot is the receivables book. Receivables to revenue sits near 90%, effectively a full year of revenue tied up in student payment plans. Management flagged bad debt at 5% of revenue and insists it is monitoring aging closely — the kind of line that deserves an eyebrow until collections turn. One caveat on the data: the fundamentals snapshot reflects the 10-Q filed in May, so the fresh Q4 and full-year figures in this call are ahead of the formal filings. The total revenue trajectory and the operating income trend are both consistent with what management is now claiming — the numbers are not the issue.

The Verdict

Legacy Education is a disciplined, debt-free, margin-expanding small-cap that just told a record-year story — and got marked down for it anyway. The market appears to be pricing two doubts the call did not resolve: negative organic starts for a second consecutive quarter, and an acquisition pipeline that has been "active" for more than a year without a single announced deal. Both are timing problems masquerading as strategy problems. Houston is the freshest reason to keep watching, but it is a 2027-2028 story, not a 2026 one. Until either starts inflect positive or a deal actually prints, the phrase acquisition opportunities under active evaluation will keep reading less like a pipeline and more like a promise on layaway.